3 results
Approved WMOCompleted
Primary objectiveTo evaluate if tralokinumab after 14 weeks of treatment (at steady state) changes the metabolism of substrates of CYP 1A2, 2C9, 2C19, 2D6, or 3A4 pathways in subjects with moderate-tosevere atopic dermatitisSecondary objectivesTo…
Approved WMOCompleted
The objective of this study is to establish the optimal intranasal cobalamin dosing regimen in elderly.
Approved WMOCompleted
In this non-inferiority trial, we aim to demonstrate that 3D-printed guides are just as good as CAS, regarding the postsurgical radiological screw-insertion accuracy.